Convergence Investment Partners LLC Invests $594,000 in Maximus, Inc. $MMS

Convergence Investment Partners LLC bought a new position in shares of Maximus, Inc. (NYSE:MMS) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund bought 6,498 shares of the health services provider’s stock, valued at approximately $594,000.

Several other hedge funds have also added to or reduced their stakes in MMS. Norges Bank acquired a new position in shares of Maximus in the second quarter valued at $47,886,000. Boston Partners boosted its holdings in shares of Maximus by 113.6% during the 2nd quarter. Boston Partners now owns 657,247 shares of the health services provider’s stock worth $46,435,000 after buying an additional 349,529 shares during the period. River Road Asset Management LLC acquired a new position in Maximus in the 2nd quarter valued at about $18,073,000. Stephens Investment Management Group LLC raised its holdings in Maximus by 49.0% in the 3rd quarter. Stephens Investment Management Group LLC now owns 720,943 shares of the health services provider’s stock valued at $65,873,000 after acquiring an additional 237,097 shares during the period. Finally, Voya Investment Management LLC lifted its position in Maximus by 1,380.3% during the third quarter. Voya Investment Management LLC now owns 228,488 shares of the health services provider’s stock worth $20,877,000 after acquiring an additional 213,053 shares during the last quarter. Institutional investors and hedge funds own 97.21% of the company’s stock.

Maximus Stock Up 0.1%

Shares of MMS opened at $94.54 on Tuesday. The company has a current ratio of 1.64, a quick ratio of 1.64 and a debt-to-equity ratio of 0.77. Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $100.00. The firm’s 50 day moving average is $90.19 and its 200-day moving average is $86.21. The stock has a market capitalization of $5.16 billion, a PE ratio of 17.00 and a beta of 0.56.

Maximus (NYSE:MMS) last issued its quarterly earnings results on Thursday, November 20th. The health services provider reported $1.62 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.01). Maximus had a return on equity of 25.23% and a net margin of 5.87%.The company had revenue of $1.32 billion for the quarter, compared to analyst estimates of $1.34 billion. During the same period in the prior year, the company earned $1.46 EPS. The company’s quarterly revenue was up .2% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 7.950-8.250 EPS. Equities research analysts forecast that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 2nd. Investors of record on Friday, February 13th will be given a $0.33 dividend. The ex-dividend date is Friday, February 13th. This is an increase from Maximus’s previous quarterly dividend of $0.30. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.4%. Maximus’s dividend payout ratio (DPR) is 21.58%.

Analyst Upgrades and Downgrades

MMS has been the topic of several research reports. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Maximus in a research report on Monday, December 29th. Zacks Research upgraded Maximus from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, December 30th. One investment analyst has rated the stock with a Strong Buy rating and one has issued a Buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Strong Buy”.

Insiders Place Their Bets

In other Maximus news, insider Michelle F. Link sold 4,039 shares of the stock in a transaction dated Wednesday, December 3rd. The shares were sold at an average price of $86.84, for a total transaction of $350,746.76. Following the sale, the insider directly owned 19,542 shares in the company, valued at $1,697,027.28. This represents a 17.13% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 1.80% of the stock is owned by corporate insiders.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.